Home/Filings/4/0001019687-14-000920
4//SEC Filing

Medytox Solutions, Inc. 4

Accession 0001019687-14-000920

CIK 0001374536operating

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 5:13 PM ET

Size

6.1 KB

Accession

0001019687-14-000920

Insider Transaction Report

Form 4
Period: 2014-03-13
Mendolia Thomas Francis DO
CEO of Company Laboratories10% Owner
Transactions
  • Award

    Restricted Stock

    2014-03-13+30,00030,000 total
Holdings
  • Series B Non-Convertible Preferred Stock

    1,000
  • Common Stock

    4,500,000
Footnotes (1)
  • [F1]This grant of restricted stock of Medytox Solutions, Inc. (the "Company") vests in full on September 13, 2014, subject to the reporting person's continued employment with the Company.

Issuer

Medytox Solutions, Inc.

CIK 0001374536

Entity typeoperating

Related Parties

1
  • filerCIK 0001374536

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 5:13 PM ET
Size
6.1 KB